Key points are not available for this paper at this time.
Background: Obesity has emerged as one of the significant public health burdens across the globe, which predisposes the risk of cardiovascular diseases and metabolic dysfunctions. Medicinal plants can be possible therapeutic measures for managing obesity. Garcinia cambogia and E. officinalis have been used for their anti-obesity and hypolipidemic properties. The objective of this study was to evaluate and compare the anti-obesity and hypolipidemic effects of Garcinia cambogia and E. officinalis in a high energy diet-induced obese rat model. Methods: A total 36 albino rats were included in the study. The animals were randomly divided into 6 groups of 6 rats each. Group 1 (control) received distilled water orally, Group 2 received Garcinia cambogia extract orally in dose of 200 mg/kg/day, Group 3 received Garcinia cambogia extract orally in dose of 400 mg/kg/day, Group 4 received E. officinalis extract orally in dose of 20 mg/kg/day, Group 5 received E. officinalis extract orally in dose of 40 mg/kg/day and Group 6 (standard) received Orlistat in dose 20 mg/kg/day. Parameters assessed included body weight and lipid profile (total cholesterol, triglycerides, LDL cholesterol, and HDL cholesterol). Results: Both Garcinia cambogia and Emblica officinalis interventions demonstrated significant reductions in body weight gain and improvements in lipid profile compared to the HED group. The intervention groups exhibited notable decreases in total cholesterol, triglycerides, and LDL cholesterol levels, along with an increase in HDL cholesterol levels. Conclusions: Our findings suggest that Garcinia cambogia and Emblica officinalis possess anti-obesity and hypolipidemic effects in a high energy diet-induced obese rat model. These naturals show promise as potential therapeutic agents for combating obesity and associated dyslipidemia. Further research is needed to understand and validate their efficacy in human populations.
Yadav et al. (2024) studied this question.